1. Prosonix Announce Agreement With Trimel Biopharma
(News/Latest)

...  Prosonix' proprietary particle engineering technologies deliver unique, crystalline, excipient free, highly performing, stable drug particles that offer significant and distinct and quantifiable advantages ...

2. Prosonix Announce Agreement With Trimel Biopharma
(News/Newsflash)

...  Prosonix' proprietary particle engineering technologies deliver unique, crystalline, excipient free, highly performing, stable drug particles that offer significant and distinct and quantifiable advantages ...

3. Prosonix Announce The Scale-Up Of UMAX technology
(News/Latest)

... proprietary UMAX® technology delivers unique, crystalline, excipient free, highly performing, stable drug particles, that offer significant and distinct and quantifiable advantages over current industry ...

4. Prosonix Announce The Scale-Up Of UMAX technology
(News/Newsflash)

... UMAX® technology delivers unique, crystalline, excipient free, highly performing, stable drug particles, that offer significant and distinct and quantifiable advantages over current industry practice, ...

5. Prosonix CEO David Hipkiss talks to in-Pharma
(News/Latest)

... of respiratory medicines.  Please see http://www.in-pharmatechnologist.com/Processing-QC/Prosonix-launches-UMAX-particle-tech-for-respiratory-drugs   For further details of the potential of UMAX® particles in ...

6. Prosonix CEO, David Hipkiss talks to in-Pharma
(News/Newsflash)

... of respiratory medicines.  Please see  http://www.in-pharmatechnologist.com/  For further details of the potential of UMAX® particles in delivering better medicines for respiratory illness and disease ...

7. Prosonix Announce The Launch Of UMAX technology
(News/Latest)

... excipient free, highly performing, stable drug particles, that offer significant quantifiable advantages over current industry practice, and now enables the development and optimization of a wide range ...

8. Prosonix Announce The Launch Of UMAX technology
(News/Newsflash)

... excipient free, highly performing, stable drug particles, that offer significant quantifiable advantages over current industry practice, and now enables the development and optimization of a wide range ...

9. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

The Prosonix power ultrasound assisted particle engineering technology UMAX®, (Ultrasound Mediated Amorphous to Crystalline transition) can be used for the manufacture of optimal particles designed and ...

10. Particles
(slider/slider)

... in the making better medicines. Technologies offer dose-to-dose uniformity, formulation consistency, stability and 200% performance increase of inhaled APIs compared to micronized. Combination particles ...

11. Ultrasonic Particle Rounding
(technology/Technology)

...      Oxcarbazepine (image left)- scale-up using Prosonitron leads to well defined rounded particles starting from more rod-like crystals. Diltiazem HCl; an hypertension API – PRT ...

12. Particle Engineering
(Pharmaceuticals/Pharmaceuticals)

... and engineered mesoscopic particles, such as in inhaled medicines including asthma, COPD and antibiotics. The size of the particle and the crystal form of the API can influence behaviour in a biological ...

13. DISCUS: Dispersive Crystallization with Ultrasound for Manufacture of Mesoscopic Particles
(technology/Technology)

... after mixing the solution is supersaturated and crystallisation occurs. Usually it is precipitation – or ‘crashing out of solution’- of amorphous and ultrafine particles due to extremes of supersaturation. ...

14. Combination Therapy
(Pharmaceuticals/Pharmaceuticals)

With SAXTM we have designed Combination Particles with every intention of manufacturing them for a brand new way to treat Asthma/COPD. The process virtually eliminates the variability associated with blending ...

15. Inhalation
(Pharmaceuticals/Pharmaceuticals)

Why should we bother to engineer particles? Formulation performance is more than just about particle size. APIs are in essence performance chemicals and it is size, morphology, surface energy, and critically ...

16. Sonocrystallization
(technology/Technology)

... microbubbles arise when the expanding pressure wave finds structural defects, such as foreign matter, particles, dust and dissolved gas. On the compression phase of the acoustic pressure wave they collapse ...

17. Pharmaceutical Manufacture
(Pharmaceuticals/Pharmaceuticals)

Pharmaceutical manufacturing is committed to making crystals and particles (although some drug substances can be viscous oils) and then modifying their properties so as to turn them into structured products. ...

18. Pharmaceutical Clients
(Pharmaceuticals/Pharmaceuticals)

... the ultrasonic particle engineering of inhaled drug particles and medicines and manufacture of a new generation of difficult-to-make generic products. Pfizer Prosonix is delighted that Pfizer have ...

19. Ultrasonic Processing
(Engineering/Engineering)

... nucleation as well as providing a mechanism to mill down, de-agglomerate or round existing particles within the liquid. The power used to drive ultrasound into the liquid is ultimately dissipated as ...

20. Scientific Advisors
(About us/about us)

... of processed particles and the general areas of particle technology and crystal growth. He has extensive contact with large pharmaceutical organisations as well as close involvement with small innovator ...